Bioxyne signs $50 million German deal by Adam Sheldon May 12, 2026May 12, 2026 Bioxyne’s Breathe Life Sciences (BLS) has inked a two-year, $50 million supply agreement with German pharmaceutical […]
Bioxyne ‘on track’ to hit guidance after sharp revenue growth in Q3 by Steve Jones April 21, 2026April 21, 2026
Domestic market could ‘double’ on back of driving law reform: Bioxyne by Adam Sheldon March 25, 2026March 25, 2026
Rec-style branding risks undermining the industry, warns Bioxyne CEO by Adam Sheldon March 12, 2026March 12, 2026
Bioxyne lifts FY26 guidance after margin growth in strong first half by Steve Jones February 26, 2026February 26, 2026
News in brief: MedReleaf expands product range; Bioxyne receives first psilocybin order; Greencare names medical lead by Steve Jones February 11, 2026June 8, 2026
Bioxyne enters Central American markets with pastille supply deal by Steve Jones December 12, 2025December 12, 2025
